Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination
收藏数据链接：
官方服务：
资源简介：
We explore how the Patent Office may improve the quality of issued patents on secondary drug features by giving examiners more time to review drug-patent applications. Our findings suggest that current time allocations are causing examiners to issue low quality secondary patents on the margin. To
提供机构：
美国国家经济研究局创建时间：
2020-07-01
